Merit study investigators announce successful achievement of the study's primary efficacy & safety endpoints

Austin, tx / accesswire / june 14, 2021 / apollo endosurgery, inc. ("apollo") (nasdaq:apen), a global leader in minimally invasive medical devices for gastrointestinal and bariatric procedures, announced that investigators of the multi-center esg randomized interventional (merit) study have reported based on a preliminary analysis the successful achievement of the study's primary endpoints. in a presentation at the 2021 surgical disruptive technologies summit meeting in houston, texas, dr. barham abu dayyeh, professor of medicine and director of advanced endoscopy at the mayo clinic, commented, "i am very pleased to report that, in a preliminary analysis, the merit study comparing the endoscopic sleeve gastroplasty (esg) procedure to medically supervised moderate intensity lifestyle modification has achieved its primary endpoints for both efficacy and safety.
APEN Ratings Summary
APEN Quant Ranking